Cargando…

Nanoparticle Targeting with Antibodies in the Central Nervous System

Treatments for disease in the central nervous system (CNS) are limited because of difficulties in agent penetration through the blood-brain barrier, achieving optimal dosing, and mitigating off-target effects. The prospect of precision medicine in CNS treatment suggests an opportunity for therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ju Hyun, Chapman, Dana V., Saltzman, W. Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AAAS 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085254/ https://www.ncbi.nlm.nih.gov/pubmed/37849659 http://dx.doi.org/10.34133/bmef.0012

Ejemplares similares

Central nervous system toxicity of metallic nanoparticles
por: Feng, Xiaoli, et al.
Publicado: (2015)

Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues
por: D’Agata, Federico, et al.
Publicado: (2017)

Antibody-mediated central nervous system diseases
por: Giannoccaro, Maria Pia, et al.
Publicado: (2018)

ACCUMULATION OF ANTIBODIES IN THE CENTRAL NERVOUS SYSTEM
por: Freund, Jules
Publicado: (1930)

Central Nervous System Targeted Protein Degraders
por: Thomas, Bedwyr ab Ion, et al.
Publicado: (2023)

Targeting of the central nervous system by Listeria monocytogenes
por: Disson, Olivier, et al.
Publicado: (2012)

Nanoparticle delivery through the BBB in central nervous system tuberculosis
por: Griego, Anna, et al.
Publicado: (2023)

Embryonal Neuromesodermal Progenitors for Caudal Central Nervous System and Tissue Development
por: Shaker, Mohammed R., et al.
Publicado: (2021)

Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System
por: Oh, Jiwon, et al.
Publicado: (2012)

The Central Nervous System and Behavior
por: May, Mark A.
Publicado: (1959)

The Role of the JC Virus in Central Nervous System Tumorigenesis
por: Ahye, Nicholas, et al.
Publicado: (2020)

Central Nervous System Targets: Supraspinal Mechanisms of Analgesia
por: Bannister, K., et al.
Publicado: (2020)

Central Nervous System Therapeutic Targets in Friedreich Ataxia
por: Harding, Ian H., et al.
Publicado: (2020)

Acute RNA Viral Encephalomyelitis and the Role of Antibodies in the Central Nervous System
por: Bartlett, Maggie L., et al.
Publicado: (2020)

Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors
por: Stopa, Brittany M., et al.
Publicado: (2022)

Autoimmune channelopathies: new antibody-mediated disorders of the central nervous system
por: Vincent, Angela
Publicado: (2009)

The lymphatic system: a therapeutic target for central nervous system disorders
por: Xu, Jia-Qi, et al.
Publicado: (2022)

Adult Neurogenesis in the Central and Peripheral Nervous Systems
por: Kim, Hyun Jung, et al.
Publicado: (2012)

Central Nervous System Targets: Inhibitory Interneurons in the Spinal Cord
por: Hughes, David I, et al.
Publicado: (2020)

Intranasal Treatment of Central Nervous System Dysfunction in Humans
por: Chapman, Colin D., et al.
Publicado: (2012)

Vascularisation of the central nervous system
por: Tata, Mathew, et al.
Publicado: (2015)

Mucormycosis of the Central Nervous System
por: Chikley, Amanda, et al.
Publicado: (2019)

Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection
por: Spatola, Marianna, et al.
Publicado: (2022)

Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice.
por: Wen, Jing, et al.
Publicado: (2019)

Targetability of the neurovascular unit in inflammatory diseases of the central nervous system
por: Smith, Brandon C., et al.
Publicado: (2022)

Autophagy in the physiology and pathology of the central nervous system
por: Nikoletopoulou, V, et al.
Publicado: (2015)

A potential therapeutic target: The role of neutrophils in the central nervous system
por: Salken, Isabel, et al.
Publicado: (2023)

Gut-central nervous system axis is a target for nutritional therapies
por: Pimentel, Gustavo D, et al.
Publicado: (2012)

Connexin: a potential novel target for protecting the central nervous system?
por: Xie, Hong-yan, et al.
Publicado: (2015)

Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted Therapeutics
por: Kram, David E., et al.
Publicado: (2018)

Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies
por: Teixeira, Maria Inês, et al.
Publicado: (2020)

Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles
por: Zhou, Lina, et al.
Publicado: (2022)

BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors
por: Talloa, Dario, et al.
Publicado: (2022)

Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system
por: Gomes, Maria João, et al.
Publicado: (2014)

Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
por: Pechlivanidou, Maria, et al.
Publicado: (2023)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors
por: Tosi, Umberto, et al.
Publicado: (2017)

Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems
por: Berkowitz, Shani, et al.
Publicado: (2021)

The Central Nervous System of Vertebrates
por: Nicholls, J. G.
Publicado: (1967)

Structure of the Central Nervous System
Publicado: (1891)

Cannot write session to /tmp/vufind_sessions/sess_898emdqfrhtns76eigeqje8avc